Comments 1 - 13 of 13 Search these comments
"the past was erased, the erasure was forgotten, the lie became the truth"
el gato malo 11 hr ago
226
it’s becoming truly amazing how much of the medical science of the past we never seemed to notice before only to see it seemingly all come to light at once…
pro tip: nothing says “guilty conscience” quite like 30 different people simultaneously answering, over and over again, a question they were never asked…
U.S.—A new study found that politicians cannot be harmed from heart issues due to the COVID-19 vaccines, as they do not have hearts that can be affected by complications such as myocarditis.
"Politicians? Oh yeah, they're totally safe from getting any kind of heart inflammation," said the head of the study, Dr. Ree Boyd. "You kinda gotta have a heart to inflame, ya know?"
Experts say the study illustrates why politicians have been so quick to get vaccinated, while ordinary humans, who have hearts, are more hesitant. "It seems people who have a heart and non-lizard blood flowing through their veins are more likely to be worried about heart issues," said Boyd. "Lizard people tend to worry more about things like how to keep harvesting humans for a food supply and the eventual total domination of our planet."
"It's just a cultural and physiological difference it would seem."
At publishing time, another study had also found that politicians are entirely safe from ever getting brain damage.
At an Oct 27 town hall meeting in Phoenix, Ariz., cardiologist Peter McCullough, M.D., emphasized the risk of myocarditis. “It is neither rare nor mild,” he said (tinyurl.com/3evyjfp8). The majority of reported cases have been in patients younger than age 20.
Estimated 1 in 95 boys diagnosed with myocarditis in a California private school
This will blow your mind, I promise. I'm pretty sure that the rate of myocarditis is a LOT more than the CDC is telling people. I think the rate is ~100X higher than they claim.
In 2010, German scientists found that a Pfizer veterinary vaccine to reduce diarrhea in cows caused a fatal bleeding disease in their calves.
Even after pressure from Germany caused Pfizer to stop selling the vaccine there, the company kept selling it elsewhere. A top Pfizer official told British farmers it was safe to use and that “other factors” were likely involved.
A month later, Pfizer stopped selling the vaccine. European regulators later found it caused a 1-in-6000 risk of the bleeding disease. “For a prophylactic measure such as vaccination this figure was considered unacceptable for a potentially fatal disorder,” the regulators found.
The risk of Covid-vaccine induced myocarditis - which can be fatal - in young men is now estimated at somewhere between 1 in 2000 and 1 in 3000.
Apparently the rules are stricter for cows.
Is COVID-19 injection-induced myocarditis mild and transient?
Nope.
... COVID-19 injection-induced myocarditis results in scar tissue replacing the damaged myocytes and this scar tissue does not have contractile function. This is what Su and Shimabukuro refer to as “recovery”. You know, the kid is still alive, it’s just that their heart has fewer functional myocytes now. Imagine you blew up a balloon after putting small pieces of tape on the surface. Those spots where the tape are would not be able to stretch and that would put extra strain and pressure on the rubbery or contractile parts of the balloon surface. Eventually, the strain would be too much and the balloon would pop from additional pressure.
Popping of heart. Where have I heard of that happening before?
In any case, I could ramble on about this, but my new paper’s coming soon so you can read my ramblings then. And the slide says it all.
This is NOT mild and NOT transient. They are LYING.
Is COVID-19 injection-induced myocarditis mild and transient?
Nope.
A team of researchers from health agencies in Finland, Denmark, Sweden,and Norway found that rates of myocarditis and pericarditis, two forms of potentially life-threatening heart inflammation, were higher in those who had received one or two doses of either mRNA-based vaccine – Pfizer’s or Moderna’s.
and no, it’s not “covid doing this” and it never was.
bad cattitude
having had covid not associated with higher rates of myo/pericarditis
it has been a “talking point of faith” for many american pundits and pharma peddlers that: “sure, vaccines may cause increased risk of myo and pericarditis, but it’s lower than the increased risk of s…
Read more
6 months ago · 582 likes · 252 comments · el gato malo
Database of Hospital ICD-10 Codes in Germany Shows AT LEAST 12-15x as Many Cases of Myo/Pericarditis Attributed to Covid Vaccines Compared to Covid
These are all cases where the OFFICIAL diagnosis was myocarditis in the context of a Vaccine Injury
Search criteria: COVID19 vaccine myocarditis
Editor's note: The publications report on patients typically presenting to emergency rooms with frank symptoms of acute myocarditis. Needless to say, not every clinician publishes on cases encountered. Unreported is symptomatic disease in those not seeking medical care, disease not properly recorded as gene therapy related, as well as those with asymptomatic disease. Long-term harm unknown. Charting the frequency of such reports over time will be instructive. And it is a necessary career preserving canard to state that benefit outweighs risk as the data underlying such a claim is non-existent.
******
STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine
Abstract
Background: In May 2021, the U.S. Food and Drug Administration expanded the Emergency Use Authorization for the Pfizer-BioNTech mRNA Coronavirus disease 2019 (COVID-19) Vaccine (BNT162b2) to include adolescents 12-15 years of age. As vaccine administration continues to increase, potential adverse outcomes, to include myocarditis, are being reported to the Vaccine Adverse Event Reporting System.
Case report: This case report describes a 17-year-old male patient who developed focal myocarditis mimicking an ST-segment elevation myocardial infarction (STEMI) 3 days after administration of an mRNA COVID-19 vaccine. Why Should an Emergency Physician Be Aware of This? Myocarditis is a rare complication in adolescents receiving mRNA COVID-19 vaccines. Focal myocarditis may demonstrate localizing electrocardiographic changes consistent with a STEMI. Overall, complications of the mRNA COVID-19 vaccines are extremely rare. The vaccine continues to be recommended by public health experts, as the benefits of vaccinations greatly outweigh the rare side effects.
https://pubmed.ncbi.nlm.nih.gov/34756746/
Acute Myocarditis after COVID-19 vaccination: A case report
Abstract in English, French
Introduction: The etiology of myocarditis often remains undetermined. A large variety of infectious agents, systemic diseases, drugs, and toxins can cause the disease. We report the case of a 19-year-old man who developed myocarditis three days after Pfizer-BioNTech COVID-19 booster vaccination.
Case report: A 19-year-old man, presenting with troponin-positive acute chest pain, was referred to our department. He had received the Pfizer-BioNTech COVID-19 vaccine three days prior to his admission. The diagnosis of acute myocarditis was confirmed by cardiovascular magnetic resonance imaging. Patient hemodynamic status remained stable during hospitalization. The left ventricular ejection fraction was preserved during hospital stay and at one-month follow-up. We found no evidence for another infectious or autoimmune etiology.
Conclusion: Although imputability of the vaccine cannot be formally established on the basis of this case report, the findings raise the possibility of an association between mRNA COVID-19 vaccination and acute myocarditis.
https://pubmed.ncbi.nlm.nih.gov/34740463/
Abstract
Myocarditis Following mRNA COVID-19 Vaccine
A growing number of adolescents are being diagnosed with acute myocarditis following mRNA COVID-19 vaccinations. This case describes an adolescent who presented to the emergency department with chest pain and tachycardia following the Pfizer-BioNTech COVID-19 vaccination. Point-of-care ultrasound was performed prior to the return of laboratory studies and revealed depressed left ventricular systolic function. Point-of-care ultrasound may be a tool used to rapidly diagnose or risk stratify patients with potential post-COVID-19 vaccine myocarditis.
https://pubmed.ncbi.nlm.nih.gov/34731877/
Myocarditis in the Setting of Recent COVID-19 Vaccination
Abstract
We report three patients who presented with chest pain after receiving either the BNT162b2 Pfizer/BioNTech or mRNA-1273 Moderna/NIH vaccine. Clinical presentation, biomarker, and cardiac MRI supported myocarditis. It is imperative that potential side effects of COVID-19 vaccine are reported to improve our knowledge about COVID-19 and mRNA vaccines.
https://pubmed.ncbi.nlm.nih.gov/34712497/
[Acute myocarditis in a young adult two days after Pfizer vaccination]
Abstract
We report the case of a 20-year-old healthy male who developed acute myopericarditis 2 days after receiving the second dose of the mRNA Pfizer-BioNTech COVID-19 vaccine. The course of the disease was mild and the patient was discharged after a few days of hospitalization.Recently, several case reports involving myopericarditis in patients who received an mRNA vaccine against SARS-CoV-2 have been published and the U.S. Centers for Disease Control and Prevention and the European Medicines Agency pharmacovigilance risk assessment committee are currently investigating an overall increased number of cases. They are also assessing whether there is a higher incidence than expected in vaccinated young adults and teenagers, especially males. Although a clear causal link has not been proven at this time, physicians should be aware of such potential adverse event, taking into account the increasing number of young people that will receive mRNA vaccination over the next few months.
https://pubmed.ncbi.nlm.nih.gov/34709227/
Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents
Abstract
Background: A possible association has been reported between COVID-19 mRNA vaccination and myocarditis. Objective: To describe cardiac MRI findings in patients with myocarditis after COVID-19 mRNA vaccination. Methods: This retrospective study included patients who underwent cardiac MRI between May 14, 2021 and June 14, 2021 for suspected myocarditis within 2 weeks of COVID-19 mRNA vaccination, without known prior COVID-19. Information regarding clinical presentation, hospital course, and postdischarge events, were recorded. A cardiothoracic imaging fellow and cardiothoracic radiologist reviewed cardiac MRI examinations in consensus. Data were summarized descriptively. Results: Of 52 patients who underwent cardiac MRI during the study period, 5 underwent MRI for suspected myocarditis after recent COVID-19 mRNA vaccination without known prior COVID-19. These 5 patients were all males with age ranging from 16 to 19 years (mean, 17.2±1.0 years) who presented within 4 days of the second dose of COVID-19 mRNA vaccine. Troponin levels were elevated in all patients (mean peak troponin I, 6.8±4.1 ng/mL). Alternate possible causes of myocarditis were deemed clinically unlikely based on medical history, physical examination, myocarditis viral panel, and toxicology screen. Cardiac MRI findings were consistent with myocarditis in all 5 patients based on Lake Louise criteria, including early gadolinium enhancement (EGE) and late gadolinium enhancement (LGE) in all patients and corresponding myocardial edema in 4 patients. All 5 patients had a favorable hospital course and were discharged in stable condition with improved or resolved symptoms after mean hospitalization length of 4.8 days. Two patients underwent repeat cardiac MRI that showed persistent, though decreased, LGE. Three patients reported mild intermittent self-resolving chest pain after discharge; 2 patients had no recurrent symptoms after discharge. Conclusion: In this small case series, all patients with myocarditis after COVID-19 vaccination were adolescent males and had a favorable initial clinical course. All patients showed cardiac MRI findings typical of myocarditis of other causes. LGE persisted in 2 patients undergoing repeat MRI. The observations do not establish causality. Clinical impact: Radiologists should be aware of the possible association of COVID-19 mRNA vaccination and myocarditis, and recognize the role of cardiac MRI in assessment of suspected myocarditis after COVID-19 vaccination.
https://pubmed.ncbi.nlm.nih.gov/34704459/
Myocarditis-induced Sudden Death after BNT162b2 mRNA COVID-19 Vaccination in Korea: Case Report Focusing on Histopathological Findings
Abstract
We present autopsy findings of a 22-year-old man who developed chest pain 5 days after the first dose of the BNT162b2 mRNA vaccine and died 7 hours later. Histological examination of the heart revealed isolated atrial myocarditis, with neutrophil and histiocyte predominance. Immunohistochemical C4d staining revealed scattered single-cell necrosis of myocytes which was not accompanied by inflammatory infiltrates. Extensive contraction band necrosis was observed in the atria and ventricles. There was no evidence of microthrombosis or infection in the heart and other organs. The primary cause of death was determined to be myocarditis, causally-associated with the BNT162b2 vaccine.
https://pubmed.ncbi.nlm.nih.gov/34664804/
A Late Presentation of COVID-19 Vaccine-Induced Myocarditis
Abstract
With the introduction of the coronavirus disease 2019 (COVID-19) mRNA vaccines, the incidence of severe infection has significantly decreased. While the vaccines have been shown to be effective and safe, there have been few case reports of acute myocarditis within 3-5 days following the second dose of the vaccine. We report a case of an elderly man who presented with acute-onset chest pain after three months of receiving the second dose of the mRNA vaccine. He was found to have acute myocarditis on cardiac magnetic resonance imaging (CMRI), which was attributed to exposure to the COVID-19 vaccine in the absence of any other risk factors. Our patient demonstrated quick resolution of symptoms and was discharged within 72 hours. We review the literature and summarize published case reports on COVID-19 vaccine-associated myocarditis. The present case report provides new evidence regarding the possible subacute presentation of myocarditis post-COVID-19 vaccine, and further highlights the favorable outcome in this newly described clinical entity.
https://pubmed.ncbi.nlm.nih.gov/34660088/
Etc., etc.